Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prevention of nosocomial Staphylococcus aureus infections after rapid detection and eradication of S. aureus carriage in patients at risk: a randomised placebo controlled multi-center trial.

Next Previous
Trial Profile

Prevention of nosocomial Staphylococcus aureus infections after rapid detection and eradication of S. aureus carriage in patients at risk: a randomised placebo controlled multi-center trial.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Feb 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Chlorhexidine (Primary) ; Mupirocin (Primary)
  • Indications Nosocomial infections; Staphylococcal infections; Surgical wound infections
  • Focus Therapeutic Use
  • Acronyms STEP

Most Recent Events

  • 15 Sep 2010 Primary endpoint results presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
  • 16 Jan 2010 Status changed from planning to completed.
  • 07 Jan 2010 Results published in the New England Journal of Medicine.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top